Hindawi Publishing Corporation Oxidative Medicine and Cellular Longevity Volume 2016, Article ID 4867124, 15 pages http://dx.doi.org/10.1155/2016/4867124 Review Article Nitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic Properties Mai E. Shoman and Omar M. Aly Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University, Minia 61519, Egypt Correspondence should be addressed to Omar M. Aly;
[email protected] Received 5 May 2015; Revised 14 August 2015; Accepted 1 September 2015 Academic Editor: Lezanne Ooi Copyright © 2016 M. E. Shoman and O. M. Aly. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Nitroxyl (HNO), the one-electron reduced form of nitric oxide (NO), shows a distinct chemical and biological profile from that of NO. HNO is currently being viewed as a vasodilator and positive inotropic agent that can be used as a potential treatment for heart failure. The ability of HNO to react with thiols and thiol containing proteins is largely used to explain the possible biological actions of HNO. Herein, we summarize different aspects related to HNO including HNO donors, chemistry, biology, and methods used for its detection. 1. Nitric Oxide (NO) cGMP in platelets, and this is thought to be the mechanism by which it inhibits platelet function [7]. In the vasculature, Biological activities associated with nitrogen oxide species are NO also prevents neutrophil/platelet adhesion to endothelial the subject of intense and current research interest.